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Abstract
A partial differential equation (PDE) was developed to describe time-
dependent ligand-receptor interactions for applications in biosensing using
field effect transistors (FET). The model describes biochemical interac-
tions at the sensor surface (or biochemical gate) located at the bottom
of a solution-well, which result in a time-dependent change in the FET
conductance. It was shown that one can exploit the disparate length
scales of the solution-well and biochemical gate to reduce the coupled
PDE model to a single nonlinear integrodifferential equation (IDE) that
describes the concentration of reacting species. Although this equation
has a convolution integral with a singular kernel, a numerical approxi-
mation was constructed by applying the method of lines. The need for
specialized quadrature techniques was obviated and numerical evidence
strongly suggests that this method achieves first-order accuracy. Results
reveal a depletion region on the biochemical gate, which non-uniformly
alters the surface potential of the semiconductor.
1 Introduction
The ability to tailor therapies to individuals or specific subsets of a population
to deliver personalized care has the potential to fundamentally remake health-
care delivery. The most promising therapeutic candidates for such targeted care
are new classes of biologic drugs based on naturally occurring molecules, made
possible due to rapid advances in genomics and proteomics [9, 23]. Importantly,
such therapies can be safer and yield better outcomes at lower doses when
treating debilitating conditions such as diabetes, Alzheimer’s disease, or certain
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cancers [2, 7]. The widespread use of personalized care is currently limited by
our ability to routinely measure pathology in individuals including biomarkers,
metabolites, tissue histology, and gene expression. Moreover, existing clinical
diagnostics are cumbersome, require specialized facilities, can take days to weeks
to perform, and are in many cases prohibitively expensive. This has led to the
development of new portable detection tools including antibody-based lateral
flow assays [8, 16], microelectromechanical sensor (MEMS) based resonators
that can detect binding of biomarkers to the sensor surface [12, 13, 18, 20], sur-
face plasmon resonance [14, 24], ring cavity resonators [1, 4, 21], and electronic
measurements with field effect transistors (FET) [6, 17, 19, 25]. The latter
are particularly well-suited for biomarker measurements due their high charge
sensitivity and direct signal transduction, allowing label-free measurements at
physiological concentrations. Furthermore, by leveraging semi-conductor pro-
cessing techniques, measurements with FETs can be made massively parallel,
cost-effective, and portable.
A FET is a three-terminal device represented in Figure 1.1. A semiconduc-
tor channel between the source and drain terminals conducts a current that is
strongly modulated by an electrostatic potential applied to the gate. Biomarkers
in aqueous solution exhibit a well-defined electrostatic surface potential [5, 11]
arising from charged hydrophilic residues that interact with water. When these
molecules adsorb to the FET biochemical gate, they strongly modulate the
channel current proportional to the magnitude of their surface potential. This
allows FETs to be used to detect and quantify adsorbed biomarkers in solu-
tion. Furthermore, functionalizing the FET, by attaching molecules to the gate
surface that have a high inherent affinity for biomarkers of interest (see Figure
1.1), allows measurements with high specificity that are tailored to one or more
biomarkers of interest.
Source Drain
Semiconductor channel
Biochemical gate
Figure 1.1: Schematic of biomarker measurements with a field effect transistor
(FET). Ligand molecules injected at the top of the solution-well diffuse and
bind with receptors immobilized on the FET biochemical gate. This schematic
is not drawn to scale. In particular, the width of the solution-well is of on the
order of millimeters, and substantially larger than the size of the biochemical
gate, which spans micrometers. See Table 2.1 for exact parameter values.
An accurate and dynamical model of receptor ligand interactions at the bio-
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chemical gate is a critical component in maximizing the sensitivity of FET-based
measurements. Specifically, quantitative descriptions of the distribution of ad-
sorbed ligands and their surface potentials can be combined with a model of the
semi-conductor physics to allow predictions of the measured signal. This in turn
can be used to optimize sensor design, particularly the geometry of the biochem-
ical gate. Of particular interest is a quantitative description of the coupling be-
tween bound ligand evolution and diffusion. To the authors’ knowledge this is a
previously unexplored area of mathematical inquiry, though Poisson-Boltzman
approaches to model sensor physics have been explored. For example in [10]
Heitzinger et al. use the Poisson-Boltzman equation to develop a multiple-scale
model for the electric potential distribution within semiconductors of planar
and nanowire field-effect biosensors. Therein, the authors model these devices
using three layers: a semiconductor layer, a dielectric layer, and a discrete layer
of biomolecules immobilized on the dieletric layer. Homogenization techniques
are employed to reconcile the biomolecule length scale with the semiconductor
length scale, and interface conditions for the biomolecule-dielectric interface are
derived. It must be noted that there are several important differences between
[10] and the present manuscript. Perhaps the most important is that while [10]
focuses on the electric potential distribution within the semiconductor chan-
nel, the present manuscript models the coupling between reaction and diffusion.
Furthermore, while the authors of [10] model the biomolecule layer with a dis-
crete number of biomolecules and use homogenization techniques, in the present
manuscript a continuum perspective is presented. Finally, [10] assumes a steady
distribution of biomolecules on the dielectric layer, while the present manuscript
concerns the time-evolution of B(x, t), which is experimentally measurable.
The authors of and [15] employ the one-dimensional Poisson-Boltzman equa-
tion to model the electrostatic potential from a layer of biological macromolecules
on the biochemical gate of a metal-oxide-semiconductor transistor. In contrast,
[3] uses a three-dimensional model of the electric potential in semiconductor
channel, and couples the aqueous and semiconductor regions through interface
conditions obtained from Monte-Carlo simulations, which provide an estimate
of the charge distribution from adsorbed biomolecules on the biochemical gate.
In [22] Heitzinger, Mauser, and Ringhofer calculate numerical values for the
kinetic parameters governing adsorption and desorption processes of CO at a
SnO2 single-nanowire gas sensor. The authors adopt a continuum perspective
by modeling surface reactions on a single-nanowire gas sensor through a set
of differential equations. However, in [22] the authors simply apply the well-
stirred kinetics approximation in which gaseous carbon monoxide transport is
completely divorced from adsorption and desorption processes at the surface.
This reduces their model to a set of nonlinear ordinary differential equations
(ODE), which can be used to estimate kinetic rate constants involved in the
reaction of interest.
In the present manuscript a quantitative description of the coupling between
reaction and diffusion in FETs is developed. In particular, we consider the
experimentally relevant limit of very low ligand concentrations—i.e., on the
order of pico- to femtomolar concentrations—and very fast assocation rates.
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This problem is particularly challenging due to the disparate time and length
scales involved. For example, the length scales span three orders of magnitude,
ranging from order of millimeters for the solution-well to micrometers for the
biochemical gate. Combining this fact with the diffusion-limited nature of the
kinetics under consideration leads to the conclusion that the time-evolution of
the reacting species concentration depends heavily on a diffusive boundary layer
near the surface.
In Section 2 a mathematical modeled is developed that describe diffusion of
ligand molecules through the solution-well onto the biochemical gate. In Sub-
section 2.1 the governing equations are presented, and it is shown that there
are multiple time and length scales associated with the experiment. In Subsec-
tion 2.2, complex analysis techniques are employed to reduce the coupled PDE
system to a single nonlinear integrodifferential equation (IDE) for the react-
ing species concentration. A quadrature-free numerical solution based on the
method of lines is developed in Section 3, where it is shown that this method
achieves first-order accuracy despite the presence of a convolution integral with
a singular kernel. Results and their physical interpretations are discussed in
Section 4, and concluding remarks are given in Section 5.
2 Governing Equations
2.1 Mathematical Model
Consider the geometry in Figure 1.1, and a rectangular domain, (x˜, y˜) ∈ [0, L˜]×
[0, H˜], with the origin (0, 0) located at the lower-left corner of the well. The
parameters L˜ and H˜ are the height and length of the well respectively; for
parameter values see Table 2.1. Throughout the manuscript tildes are used
to denote dimensional quantities. Receptors are confined to the biochemical
gate, which occupies the very narrow region (x˜, y˜) ∈ [−l˜s/2 + L˜/2, L˜/2 +
l˜s] × 0 = [x˜min, x˜max] × 0, where l˜s denotes length of the biochemical gate and
[x˜min, x˜max] := [−l˜s/2 + L˜/2, L˜/2 + l˜s]. It is important to note that while the
length scale of the well is on the order of millimeters, the length scale of the
biochemical gate is on the order of micrometers.
Assuming that ligand molecules are continuously and uniformly injected
at the top of the well, ligand transport is governed by the diffusion equation
expressed in dimensionless form as:
∂C
∂t
= Dw
(
ǫ2
∂2C
∂x2
+
∂2C
∂y2
)
, (2.1a)
C(x, y, 0) = 0, (2.1b)
C(x, 1, t) = 1 (2.1c)
∂C
∂x
(0, y, t) =
∂C
∂x
(1, y, t) = 0. (2.1d)
Equation (2.1a) is the diffusion equation, (2.1b) is the initial condition, (2.1c)
4
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Dimensional Parameters Dimensionless Parameters
Parameter Range Parameter Range
D˜ (cm2/s) 10−6 Dw 2.5× 10
−2 to 2.5× 102
k˜a (cm
3 · (mol · s)−1) 1011 to 1012 D 4× 103 to 4× 107
k˜d (s
−1) 10−5 to 1 Daw 1.33× 10
3 to 2.66× 103
C˜u (mol · cm
−3) 10−18 to 10−15 Da 3.32 to 66.42
R˜t (mol · cm
−2) 6.6422× 10−14 to 1.3284× 10−13 K 10−2 to 106
H˜ (cm) 0.2 ǫ 0.4
L˜ (cm) 0.5 ls 10
−3
l˜s (cm) 5× 10
−4
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is the uniform injection condition, and (2.1d) are no-flux conditions which hold
on the sides of the well. In writing (2.1a)–(2.1d), we have nondimensionalized
the spatial variables x˜ and y˜ using the well dimensions by setting x = x˜/L˜ and
y = y˜/H˜. Additionally, since we are interested in reaction dynamics on the
sensor surface, the time variable has been scaled by the forward reaction rate
t = k˜aC˜ut˜. Here C˜u is the uniform injection concentration at the top of the well.
In (2.1a)–(2.1d) ǫ = O(1) is the aspect ratio, and
Dw =
D˜
H˜2k˜aC˜u
=
D˜/H˜2
k˜aC˜u
(2.2)
is a dimensionless constant that scales the diffusive time, D˜/H˜2, to the forward
reaction time, k˜aC˜u. The subscript w indicates that the independent variables
are scaled with the well dimensions. It is seen in Table 2.1 that Dw = O(10
−3)
to O(10) which implies that the the reaction at the biochemical gate is diffusion-
limited, as expected for femtomolar ligand concentrations C˜u.
To state the bottom boundary condition associated with (2.1a)–(2.1d) we
observe that when (x, y) 6∈ [xmin, xmax]× 0 there is no flux through the surface
of the well, while when (x, y) ∈ [xmin, xmax]× 0 the diffusive flux normal to the
binding surface is used in forming the bound ligand . These two conditions are
expressed compactly as:
(n · ∇C)|y=0 = Daw χs [−(1− B˜)C˜(x, 0, t) +KB]. (2.3)
In (2.3) n = (0,−1) denotes the outward unit normal vector, χs is the charac-
teristic function defined as
χs(x) =
{
1 x ∈ [xmin, xmax],
0 x 6∈ [xmin, xmax],
(2.4)
and K = k˜d/(k˜aC˜u) is the dimensionless equilibrium dissociation rate constant.
Furthermore, since the bound ligand concentration is governed by the kinetics
equation
∂B
∂t
= (1 −B)C(x, 0, t)−KB, (2.5a)
B(x, 0) = 0, (2.5b)
we can express (2.3) as
∂C
∂y
(x, 0, t) = Daw
∂B
∂t
. (2.6)
The complete partial differential equation system is given by (2.1), (2.5), and
(2.6).
In (2.3) and (2.6), the important dimensionless parameter
Daw =
H˜k˜aR˜t
D˜
=
k˜aR˜t
D˜/H˜
(2.7)
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is the Damko¨hler number, which is the ratio of reaction velocity to diffusion
velocity. Note that both the numerator and denominator have dimensions of
unit length per unit time. It is seen in Table 2.1 that Daw ≫ 1, which implies
that reaction velocity is much faster than diffusion velocity. This is a direct
consequence of the fact that there are multiple time and length scales associated
with the experiment: ligand molecules must diffuse a distance on the order
of millimeters to arrive at the biochemical gate, and the speed at which this
transpires is far slower than the reaction velocity, i.e., the reaction is diffusion
limited.
Using the fact that Daw ≫ 1 reduces (2.6) to
∂B
∂t
= 0, (2.8)
which implies that, to leading-order, B(x, t) is in a steady-state. Substituting
(2.8) into (2.5) yields
C(x, 0, t) =
KB
1−B
. (2.9)
This reflects the transport-limited nature of the kinetics system under consider-
ation. To study the reaction dynamics we must examine the diffusion of ligand
molecules in the vicinity of the biochemical gate. We introduce boundary layer
coordinates,
x =
x− 1/2
ls
, y =
ǫ
ls
y. (2.10)
In (2.10)
ls =
l˜s
L˜
(2.11)
is the ratio of biochemical gate length l˜s to the well length L˜, and is very small.
Introducing these scalings into (2.1a)–(2.1d) and (2.6) yields
∂C
∂t
= D
(
∂2C
∂x2
+
∂2C
∂y2
)
, (2.12a)
C(x, y, 0) = 0, (2.12b)
C(x, ǫ/ls, t) = 1, (2.12c)
∂C
∂x
(−1/(2ls), y, t) =
∂C
∂x
(1/(2ls), y, t) = 0, (2.12d)
∂C
∂y
(x, 0, t) = Da
∂B
∂t
χs. (2.12e)
Furthermore, the kinetics equation (2.5) becomes
∂B
∂t
= (1 −B)C(x, 0, t)−KB, (2.13a)
B(x, 0) = 0. (2.13b)
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Observe that transitioning to boundary layer coordinates has the effect of
rescaling Dw and Daw. The parameter
D =
D˜
l˜2s k˜aC˜u
=
D˜/l˜2s
k˜aC˜u
(2.14)
is the dimensionless diffusion coefficient on this length scale, and is the ratio of
the diffusive time scale over a region of size l˜2s to the forward reaction rate. From
Table 2.1 it is seen thatD ≫ 1, which implies that diffusion within the boundary
layer is much faster than the forward reaction rate. This is not surprising as we
are considering picomolar to femtomolar ligand concentrations. Furthermore
Da =
k˜aR˜t l˜s
D˜
=
k˜aR˜t
D˜/l˜s
(2.15)
is the Damko¨hler number associated with these length scales. Since Da is an
O(1) to O(10) parameter, on these length scales the reaction velocity is the
same as or only slightly faster than the diffusion velocity. Equation (2.12e) then
implies that reaction balances diffusion within the boundary layer.
2.2 Integrodifferential Equation Reduction
SinceD ≫ 1, we neglect the left hand side of (2.12a) which reduces this equation
to
∇2C = 0. (2.16)
Physically, equation (2.16) implies that near the surface C is in a quasi-steady-
state and change in the unbound concentration is driven by the surface-reaction
(2.12e). Furthermore, since ls ≪ 1 we are not concerned with satisfying the
no-flux conditions (2.12d) and take our domain to be the infinite strip R ×
[0, ǫ/ls]. This idealization is physically motivated and justified by the fact that
the biochemical gate occupies a very narrow portion of the well surface, so the
walls of the well will not appreciably affect ligand binding.
To solve the resulting set of PDEs we seek solutions of the form
C(x, y, t) = 1 + Cb(x, y, t), (2.17)
where Cb satisfies
∇2Cb = 0, (2.18a)
Cb(x, ǫ/ls, t) = 0, (2.18b)
∂Cb
∂y
(x, 0, t) = Da
∂B
∂t
χs, (2.18c)
for (x, y) ∈ R× [0, ǫ/ls]. To solve (2.18) we introduce a Fourier transform in x,
defining the Fourier transform as
(Fu)(ω) := uˆ(ω) =
∫ ∞
−∞
u(x)eiωx dx, (2.19a)
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so that the inverse Fourier Transform is given by
(F−1uˆ)(x) = u(x) =
1
2π
∫ ∞
−∞
uˆ(ω)e−iωx dx. (2.19b)
Applying a Fourier transform to (2.18) and solving the resulting equations in
the frequency domain gives
Ĉb(ω, y, t) = −
Da sinh((ǫl−1s − y)ω)
ω cosh(ǫl−1s ω)
∂B̂
∂t
(ω, t) ⋆
(
sin(ω/2)
ω/2
)
, (2.20)
where the convolution product ⋆ has been defined so that
∂B̂
∂t
(ω, t) ⋆
(
sin(ω/2)
ω/2
)
=
∫ ∞
−∞
∂B̂
∂t
(ω − ν, t)
sin(ν/2)
ν/2
dν. (2.21)
However, in order to study the dynamics of interest a closed-form of C(x, y, t)
on the surface y = 0 is required. This is aquired by applying the convolution
theorem after calculating
f(x) =
1
2π
∫ ∞
−∞
tanh(aω)
ω
e−iωx dω. (2.22)
Observe that when x = 0 the integrand decays at a rate of 1/ω as ω → ±∞.
Thus the integrand of (2.22) is not integrable when x = 0, and f is singular
at the origin. The evaluation of (2.22) may then be separated into two cases:
when x > 0 and when x < 0. We consider the latter by constructing a sequence
of contours in the complex plane in the manner depicted in Figure 2.1. To fix
notation we let C(n) =
∑
C
(n)
j .
Re ω
Im ω
ρn−ρn Rn−Rn
C
(n)
2
C
(n)
4
C
(n)
1 C
(n)
3
Figure 2.1: The contour used to calculate (2.22) when x < 0.
The hyperbolic tangent function has countably infinite singularities along
the imaginary axis, so the path of integration cannot intersect any of these
9
singularities. The singularities will occur when ω = 0 or
ω =
πi(2n+ 1)
2a
. (2.23)
Note the contour depicted in Figure 2.1 does not pass through the singularity
at the origin; in fact, since
lim
ω→0
tanh(aω) = 0 (2.24)
this singularity would not have contributed to (2.22) if we had placed the semi-
circle of radius ρn in the lower half-plane. Thus taking the radii of our semi-
circles to be
ρn = π/((n+ 2)a), (2.25a)
Rn = πn/a, (2.25b)
the path of integration will never intersect any of the singularities and Cauchy’s
Residue Theorem may be applied:∮
C(n)
tanh(aω)
ω
e−iωx dω = 2πi
n−1∑
k=0
I(C(n), ak) Res
(
tanh(aω)
ω
e−iωx;αn
)
.
(2.26)
Calculating residues and letting n approach infinity gives
lim
n→∞
∮
C(n)
tanh(aω)
ω
e−iωx dω = 4
∞∑
k=0
e(2k+1)πx/(2a)
(2k + 1)
. (2.27)
On the other hand,
lim
n→∞
∮
C(n)
tanh(aω)
ω
e−iωx dω = lim
n→∞
4∑
j=1
∮
C
(n)
j
tanh(aω)
ω
e−iωx dω. (2.28)
One may show that the integral along C
(n)
2 vanishes as n→∞, and by using the
fact that x < 0 one may similarly show that the integral along the far contour
C
(4)
2 vanishes. From these facts and the Maclaurin series for tanh
−1(x) it follows
that
f(x) =
2
π
tanh−1(eπlsx/(2ǫ)) (2.29)
when x < 0. To evaluate (2.22) when x > 0 one may extend this integral to
the complex plane by using the reflection of the contour depicted in Figure 2.1
about the real axis, shown in Figure 2.2, and use analogous arguments to show
f(x) =
2
π
tanh−1(e−πlsx/(2ǫ)) (2.30)
when x > 0.
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Re ω
Im ω
ρn−ρn Rn−Rn
C
(n)
2
C
(n)
4
C
(n)
1 C
(n)
3
Figure 2.2: The contour used to calculate (2.22) when x < 0.
In summary the integral (2.22) is singular at the origin, given by (2.29) when
x < 0, and (2.30) when x > 0. Putting these three observations together leads
to the conclusion that
f(x) = tanh−1(e−πls|x|/(2ǫ)). (2.31)
Thus applying the convolution theorem to (2.20) evaluated at y = 0 and sub-
stituting the resulting expression into (2.17) gives:
C(x, 0, t) = 1−
2 Da
π
∫ 1/2
−1/2
tanh−1(e−πls|x−ν|/(2ǫ))
∂B
∂t
(ν, t) dν. (2.32)
Hence, the bound ligand concentration is governed by the IDE
∂B
∂t
= (1− B)
(
1−
2 Da
π
∫ 1/2
−1/2
tanh−1(e−πls|x−ν|/(2ǫ))
∂B
∂t
(ν, t) dν
)
−KB,
(2.33a)
B(x, 0) = 0. (2.33b)
In (2.32) the term 1 represents the uniform injection concentration and the
convolution integral represents depletion of unbound ligand at the surface due
to reaction. As we shall see in Section 4 the non-local nature of the convolution
(2.32) reflects the probabilistic nature of diffusion in the boundary layer near
the surface, and the finite limits of integration encode the reflective boundary
conditions to the left and right of the biochemical gate. However, we first turn
our attention to finding a numerical approximation to the solution of (2.33).
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3 Numerical Method
3.1 Method of Lines Approximation
To discretize (2.33a) we choose N equally-spaced discretization nodes xi and
partition [−1/2, 1/2] into N distinct subintervals of length ∆x = 1/N :[
−
1
2
,
1
2
]
=
N⋃
i=1
[
xi −
∆x
2
, xi +
∆x
2
]
, (3.1)
where −1/2 = x1 − ∆x/2 and 1/2 = xN + ∆x/2. Then an approximation to
(2.33) is found by applying the method of lines
B(x, t) ≈
n∑
i=1
hi(t)φi(x) (3.2)
where the functions hi(t) are to be determined and subject to the initial condi-
tion hi(0) = 0, and the functions φi(x) are locally defined piece-wise linear hat
functions
φi(x) =

2
∆x
[x− (xi −∆x/2)] if x ∈ [xi −∆x/2, xi),
2
∆x
[(xi +∆x/2)− x] if x ∈ [xi, xi +∆x/2],
0 else.
(3.3)
Substituting (3.2) into (2.33a) and evaluating each side of the resulting equation
at x = xj yields
h′j(t) = (1− hj(t))
(
1−
N∑
i=1
2 Da h′i(t)
π
∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi(ν) dν
)
−Khj(t),
(3.4)
for j = 1, . . . , N . The solution of this nonlinear set of ODEs determines the
time-dependent functions hj(t), however solving this system requires computing∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi(ν) dν. (3.5)
Since tanh−1(e−|xj−ν|πls/(2ǫ)) exhibits logarithmic singularity at ν = xj , com-
puting (3.5) using a quadrature rule requires great care, although (3.5) may be
evaluated exactly. This is done by decomposing the basis functions (3.3) into
their left and right parts:
φi,l(x) =

2
∆x
[x− (xi −∆x/2)] if x ∈ [xi −∆x/2, xi),
0 else,
(3.6)
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and
φi,r(x) =

2
∆x
[(x + xi)−∆x/2] if x ∈ [xi, xi +∆x/2],
0 else.
(3.7)
Having decomposed the basis functions into their left and right parts (3.5) can
be written as∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi(ν) dν =
∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi,l(ν) dν
+
∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi,r(ν) dν.
(3.8)
Since the two terms on the right hand side are related through a change of
variables, it is sufficient to calculate∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi,l(ν) dν. (3.9)
After changing variables, one may use the definition of tanh−1(·) and expand
the integrand in terms of its Mclaurin series to find that it is a telescoping sum:∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi,l(ν) dν (3.10)
=
∞∑
n=0
2
∆x
∫ ∆x/2
0
e−|w−xj+xi−∆x/2|(2n+1)/(2ǫ)
2n+ 1
w dw. (3.11)
In writing (3.11) we have formally exchanged the limit operations. Observe that
the absolute value prevents one from integrating by parts directly; however, by
using the fact that the discretization nodes are equally spaced one can show
the computation may be partitioned in two distinct cases: when xj ≥ xi and
xj < xi. Since the computation is analogous in each case we concern ourselves
only with the former. Thus taking xj ≥ xi and integrating the right hand side
of (3.11) by parts shows that (3.9) is equal to
∞∑
n=0
(
2
∆x
)(
∆xǫ e−(xj−xi)(2n+1)πls/(2ǫ)
(2n+ 1)2πls
−
4ǫ2 e−(xj−xi)(2n+1)πls/(2ǫ)
(2n+ 1)3π2l2s
+
4ǫ2 e−[∆x/2+(xj−xi)](2n+1)πls/(2ǫ)
(2n+ 1)3π2l2s
)
.
(3.12)
To sum the series (3.12), we observe that one can use the definition of the
polylogarithm of order s
Lis(z) =
∞∑
k=1
zk
ks
(3.13)
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to show
∞∑
n=0
z2n+1
(2n+ 1)s
= Lis(z)−
1
2s
Lis(z
2). (3.14)
Hence when xj ≥ xi∫ 1/2
−1/2
tanh−1(e−|xj−ν|πls/(2ǫ))φi,l(ν) dν
=
(
2
∆x
)[
∆xǫ
πls
(
Li2(e
−(xj−xi)πls/(2ǫ))− Li2(e
−(xj−xi)πls/(ǫ))/4
)
−
4ǫ2
π2l2s
(
Li3(e
−(xj−xi)πls/(2ǫ))− Li3(e
−(xj−xi)πls/(ǫ))/8
)
+
4ǫ2
π2l2s
(
Li3(e
−[∆x/2+(xj−xi)]πls/(2ǫ))− Li3(e
−[∆x/2+(xj−xi)]πls/(ǫ))/8
)]
.
(3.15)
The form of (3.15) when xj < xi is similar. With the exact value of (3.8),
the nonlinear set of ODEs (3.4) may be integrated with one’s favorite linear
multistage or multistep formula.
3.2 Convergence
Convergence of the numerical method outlined in the previous subsection was
measured by first computing a reference solution Bref(x, t) on a mesh with
N = 37 = 2187 spatial discretization nodes; this was done by integrating (3.4)
from t = 0 to t = 150 using an adaptive linear multistage formula. Then
solutions Bi(x, t) were computed on meshes with N = 3
i nodes and convergence
was measured by calculating
|| ||Bref(x, t)−Bi(x, t)||2, x||∞, t (3.16)
for i = 1, . . . , 6. In (3.16) || · ||2, x denotes l2 norm in x and || · ||∞, t denotes
the infinity norm in t. A logarithmic plot of these values is depicted in Figure
3.1. Despite the logarithmic singularity in (2.33a), the evidence in Figure 3.1
strongly suggests that our method of lines approximation to (2.33) achieves first-
order convergence. Although it is of interest to derive analytic error estimates
for our approximation, the nonlinearity in (2.33a) precludes analysis.
4 Results and Discussion
The results of our numerical simulations are depicted in Figure 4.1. Upon in-
spection one immediately notices the presence of a depletion region in the center
of the biochemical gate for small t. As time progresses, the depletion regions
narrows and becomes more shallow as the rate of bound ligand production near
the boundary decreases. The bound ligand concentration continues to become
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Figure 3.1: The values of (3.16) for i = 1, . . . , 6 depicted together with the
line y = −1.0762x − 4.2067, which was fit to the values of (3.16) with an R2
coefficient of R2 = .9987. Parameter values of Da = 66.42, K = 1, ls = 10
−3,
and ǫ = 1 were used.
(a) Space-time curve of B(x, t) for t in the
interval [0, .1]
(b) Space-time curve of B(x, t) for t in the
interval [0, 10].
(c) Space-time curve of B(x, t) for t in the
interval [0, 50].
(d) Space-time curve of B(x, t) for t in the
interval [0, 150].
Figure 4.1: Method of lines approximation to the solution of (2.33) during
different time intervals. Parameter values of Da = 66.42, K = 1, ls = 10
−3, and
ǫ = 2/5 were used.
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more spatially uniform until a chemical equilibrium is achieved, resulting in a
balance between association and dissociation.
Mathematically, the depletion region results from the singular convolution
kernal
tanh−1(e−|(x−ν)|πls/(2ǫ)) (4.1)
and the finite limits of integration. In Figure 4.2 the convolution kernel has been
depicted, centered at both x = 0 and x = −1/2. When the convolution kernel
is centered at x = 0 it acts as a two-sided influence function. The singularity
at x = 0 reflects the high likelihood that a ligand molecule directly above the
origin will diffuse to the surface and bind with an available receptor site there;
however, in the unstirred layer ligand molecules diffusing into the surface bind
with neighboring receptor sites. Figure 4.2 reveals the likelihood of binding
with a neighboring receptor site decays with the distance away from the source,
although it is never zero since tanh−1(e−|x−ν|πls/(2ǫ)) is supported everywhere
on the real line, and in particular everywhere on [−1/2, 1/2]. Conversely, when
the kernel is centered at x = −1/2 Figure 4.2 shows that it acts as a one-sided
influence function. The finite limits of integration in (2.33a) imply that the
convolution kernel influences the bound ligand concentration the most at x =
−1/2, and has a monotonically decreasing influence progressing from x = −1/2
to x = 1/2. Thus the finite limits of integration encode the reflective boundary
conditions. To the right of x = −1/2 ligand molecules spread out and diffuse
into the surface, while to the left they are merely reflected.
-0.6 -0.4 -0.2 0 0.2 0.4 0.6
ν
3.5
4
4.5
5
Convolution Kernal
x = 0
x = −1/2
Figure 4.2: The convolution kernal tanh−1(e−|x−ν|πls/(2ǫ)) centered at x = 0
(solid line), and at x = −1/2 (dotted line). Parameter values of ls = 10
−3 and
ǫ = 2/5 were used.
The average concentration across the biochemical gate
B(t) =
∫ 1/2
−1/2
B(x, t) dx (4.2)
is shown in Figure 4.3a for three values of k˜a. This quantity is proportional
to the electrostatic potential applied to the biochemical gate, and thereby the
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electric current across the semi-conducting channel, allowing direct compar-
ison to measurements. Increasing the association rate constant results in a
larger Damko¨hler number. This reflects the enhanced rate of reaction relative
to transport, and corresponds to wider and deeper depletion regions that impede
current flow near the boundaries of the biochemical gate before the rest of the
semiconductor channel. This is a remarkable result that is not directly observ-
able experimentally, and provides physical insight into the origin of the signal
measured with a FET. Finally, the transient phase of the signal grows with the
association rate constant, owing to both decreasing the equilibrium dissociation
rate constant and increasing the rate of reaction relative to diffusion.
Increasing the ligand concentration C˜u increases the average concentration at
the biochemical gate, resulting in higher FET conductance. From Figure 4.3b it
is seen that the equilibrium value of B increases with the ligand concentration
C˜u, as expected since the ligand concentration and equilibrium dissociation
rate constant are inversely proportional. These considerations are clearly of
fundamental importance for parameter estimation.
0 50 100 150
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0.4
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0.8
1
(a) The average concentration has been
depicted for k˜a = 1011, 5 × 1011, and
1012 cm3/(mol · s). This corresponded to
Da = 6.64, 33.21, and 66.42; and K =
1.67, 0.33, and 0.17. In addition parame-
ter values of ls = 10−3, and ǫ = 2/5 were
used.
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(b) The average concentration has been de-
picted for C˜u = 10−17, 5 × 10−17, and
10−16 mol/cm3. This corresponded toK =
10, 2, and 0.2. In addition parameter val-
ues of Da = 6.6420, ls = 10−3, and ǫ = 2/5
were used.
Figure 4.3: The average concentration (4.2) for different values of k˜a and C˜u.
5 Conclusions
The ability to tailor therapies to individuals or specific subsets of a population
could transform medicine. However, widespread use of personalized therapeu-
tics has yet to be adopted due to our inability to quickly and routinely measure
biomarkers. Not only do FETs exhibit high charge sensitivity and provide direct
signal transduction, they also provide label-free measurements at physiological
concentrations. As such, FETs are an incredibly promising tool for biomarker
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measurement. Although an accurate dynamical model for receptor-ligand dy-
namics is necessary for maximizing the sensitivity of these instruments, all pre-
vious modeling efforts have been devoted to the study of steady-state sensor
physics. Herein, a time-dependent model for receptor ligand dynamics has been
presented for the first time.
This model takes the form of a diffusion equation, coupled to an equation
describing reaction on the biochemical gate. Analysis of this set of nonlinear
equations is complicated by the presence of multiple disparate time and length
scales: ligand molecules must diffuse a distance on the centimeters to arrive
at the reacting surface, which is on the order of micrometers. Furthermore,
diffusion is a very slow process while the reactions of interest proceed very
quickly. Nevertheless, by using the appropriate characteristic time and length
scales one is able to reduce this model to a quasi-steady transport equation
for the unbound ligand concentration C, coupled to an equation describing
the evolution of the bound ligand concentration B. Employing the residue
theorem allows one to further reduce this set of equations to a single nonlinear
IDE in terms of the reacting species concentration. Despite the presence of a
singular convolution kernel, this equation has been solved to first-order accuracy
without the need to resort to specialized quadrature techniques to evaluate (3.5).
Results of our numerical simulations reveal the presence of a depletion region
in the center of the biochemical gate, which influences the current signal by
non-uniformly altering the surface-potential of the semiconductor channel.
In addition to providing a time-dependent model for estimating binding
affinities, the present model could be coupled to a model for semiconductor
physics to refine theoretical predictions and serve as a basis for sensor optimiza-
tion. The latter may be a subject of future investigation. Additionally, it is
of interest to study receptor-ligand dynamics in FETs under a different experi-
mental conditions; i.e. a sealed experiment wherein a drop of ligand molecules
is injected at an instance of time. Extending the present model to higher ge-
ometries is also of interest.
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